Jeremie Calais, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA, discusses the future of radioactive imaging and theranostics in the diagnosis and treatment of prostate cancer and highlights the possibility of novel targets for imaging and treatment in addition to PSMA. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
Ещё видео!